While there is no proven best time to take collagen for weight loss, some people report that using collagen before a meal may ...

Improvements to the U.S. supply chain are needed to reduce shortages and protect American patients. Industry, academia, ...

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.

CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green ...

A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...

Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain ...

“Partnering with John ‘Shrek’ McPhee, reinforces our commitment to making testosterone therapy accessible and effective,” said Marius Pharmaceuticals CEO Shalin Shah, adding, “With KYZATREX’s ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral ...

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.